Yingjiao Cao
- Immunology top 10%
- IL-33, ST2, and ILC Pathways 5
- Immune Response and Inflammation 4
- Immune cells in cancer 4
- Immune Cell Function and Interaction 4
- Inflammation biomarkers and pathways 2
-
- Eosinophilic Esophagitis 4
-
- Inflammatory mediators and NSAID effects 2
-
- Neonatal Respiratory Health Research 2
- Cited by
- ImmunologyCancer ResearchOncology
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Yingjiao Cao
15 papers receiving 434 citations
Peers
Comparison fields: 5 of 55
- Immunology 263
- Cancer Research 115
- Oncology 91
- Molecular Biology 198
- Clinical Biochemistry 14
Countries citing papers authored by Yingjiao Cao
This map shows the geographic impact of Yingjiao Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingjiao Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingjiao Cao more than expected).
Fields of papers citing papers by Yingjiao Cao
This network shows the impact of papers produced by Yingjiao Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingjiao Cao. The network helps show where Yingjiao Cao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yingjiao Cao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 9 | |
| 5 | 2023 | 3 | |
| 6 | 2022 | 2 | |
| 7 | 2020 | 12 | |
| 8 | 2020 | 8 | |
| 9 | 2019 | 31 | |
| 10 | 2019 | 7 | |
| 11 | 2018 | 242 | |
| 12 | 2018 | 17 | |
| 13 | 2017 | 44 | |
| 14 | 2016 | 38 | |
| 15 | 2014 | 20 |
About Yingjiao Cao
Yingjiao Cao is a scholar working on Immunology, Gastroenterology and Clinical Biochemistry, having authored 15 papers that have together received 439 indexed citations. Recurring topics across this work include IL-33, ST2, and ILC Pathways (5 papers), Eosinophilic Esophagitis (4 papers), Immune Response and Inflammation (4 papers), Immune cells in cancer (4 papers), Immune Cell Function and Interaction (4 papers), Inflammation biomarkers and pathways (2 papers), Inflammatory mediators and NSAID effects (2 papers) and Neonatal Respiratory Health Research (2 papers). The work is most often cited by research in Immunology (263 citations), Cancer Research (115 citations) and Oncology (91 citations). Yingjiao Cao has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Linsen Ye, Jie Zhou, Liting Zhang, Guihua Chen, Yusheng Cheng, Qi Zhang, Genshu Wang, Xiaolong Chen, Tong Zhang and Yinan Deng. Their work appears in journals such as Proceedings of the National Academy of Sciences, Blood and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.